Ran Geng

Ran Geng currently serves as Director at OrbiMed, where responsibilities include overseeing collaborations with various biopharmaceutical companies. Prior experience includes a Vice President role at Matrix Partners, where Ran Geng sourced and led investments in several biotech firms. In earlier positions, Ran Geng worked as an Associate and Senior Analyst at Life Science Angels and ZS Associates, contributing to key M&A strategies and clinical trial designs for major pharmaceutical companies. Educational qualifications include a Master’s in Biomedical Informatics from Stanford University School of Medicine, a BSE in Operations and Management from The Wharton School, and a BA in Computational Biology from the University of Pennsylvania, along with admission to an 8-Year M.D. Program at Peking University.